Nexalin Technology, Inc.
NASDAQ: NXL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mark White
- Employees
- 6
- Headquarters
- Houston, United States
- IPO year
- 2022
- Market cap
- $6.9M
- Website
- https://www.nexalin.com
Loading NXL…
Loading profile data…Frequently asked questions about NXL
What does Nexalin Technology, Inc. (NXL) do?
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia....
Where does NXL trade?
Nexalin Technology, Inc. (NXL) trades on the NASDAQ Capital Market.
What sector is NXL in?
Nexalin Technology, Inc. (NXL) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Nexalin Technology, Inc.?
Mark White is the chief executive officer of Nexalin Technology, Inc. (NXL).
Where is Nexalin Technology, Inc. headquartered?
Nexalin Technology, Inc. is headquartered in United States.
Does NXL pay a dividend?
Nexalin Technology, Inc. (NXL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NXL go public?
Nexalin Technology, Inc. (NXL) completed its initial public offering in 2022.